Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0001810417-26-000010 |
|---|---|
| Form Type | 4 |
| Filing Date | May 7, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
141,000
Total Value
$1,326,601.90
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | May 6, 2026 | Exercise/Conversion | 47,000 | $8.04 | $377,880.00 | 47,423 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | May 6, 2026 | Sale | 13,834 | $18.55 | $256,655.28 | 33,589 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | May 6, 2026 | Sale | 12,347 | $19.28 | $238,093.37 | 21,242 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | May 6, 2026 | Sale | 2,700 | $20.76 | $56,052.00 | 18,542 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | May 6, 2026 | Sale | 9,219 | $21.37 | $197,008.19 | 9,323 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | May 6, 2026 | Sale | 8,900 | $22.57 | $200,913.05 | 423 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | May 6, 2026 | Exercise/Conversion | 47,000 | $0.00 | $0.00 | 116,000 | Direct | โ | View Details |